UPDATE: Barclays Downgrades Endo International plc (ENDP) to Underweight

March 2, 2022 3:48 AM EST
Get Alerts ENDP Hot Sheet
Price: $0.29 --0%

Rating Summary:
    14 Buy, 15 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 2 | Down: 23 | New: 24
Join SI Premium – FREE
(Updated - March 2, 2022 6:55 AM EST)

Barclays analyst Balaji Prasad downgraded Endo International plc (NASDAQ: ENDP) from Equalweight to Underweight with a price target of $2.00 (from $5.00).

The analyst comments "We see 3 headwinds for 2022: 1) Lowered confidence on Qwo; 2) Weaker Xiaflex growth; 3) Q1 Vaso guide already at ~30% Y/Y decline - we expect consensus to lower materially, closer to our 50% decline. Combined with Opioids overhang & limited positives in sight, we see a difficult path for the stock to perform. Move to UW."

For an analyst ratings summary and ratings history on Endo International plc click here. For more ratings news on Endo International plc click here.

Shares of Endo International plc closed at $2.41 yesterday.

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Downgrades

Related Entities